Evodiamine treatment of human melanoma A375-S2 induced cell death that was mediated through PI3K/Akt/caspase and Fas-L/NF-κB signaling pathways and this effect was synergized upon treatment with ubiquitin-proteasome inhibition [127]. Here, AKT1 is linked to melanoma.